Blood Transfusion; Hemoglobinemia, Cardiac Disease, Thoracic Surgery
Conditions
Brief summary
The primary objective of this study is to analyze mortality after cardiac surgery in blood-transfusion non-acceptors (BTNA), and the secondary one to perform an adjusted comparison with a blood-transfusion acceptors (BTA) matched cohort.
Interventions
Patients who do not accept blood products transfusions
Patients who accept blood products transfusions
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients undergoing heart surgery in our hospital from 2009 to June 2020
Exclusion criteria
* Preoperative hemoglobin lower than 120g/L * EuroSCORE-II higher than 20% * Heart transplant * Assist device implantation * Surgery of acute myocardial infarction-derived complications * Other emergent cardiac surgeries (acute aortic dissection, heart injuries).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change on Hemoglobin values from preoperative to end-of-surgery levels | End-of-surgery | Changes on Hemoglobin values in percentage from preoperative level to the end of the surgery level |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of operative mortality | At discharge or within the first 30 postoperative days | Any death occurring i) within the first 30 postoperative days in or out of the hospital, and ii) after 30 days during the same hospitalization subsequent to the operation. |
| Intraoperative fluid balance | End of surgery | Resting the fluid outputs to inputs |
| Hemoglobin at discharge | At discharge, an average of 10 days | Hemoglobin level at discharge |
| Rate of postoperative morbidity | At discharge, an average of 10 days | Postoperative complications: hemodynamic, respiratory, renal, neurological, infective complications |
Countries
Spain